Search Within

OVARIAN CANCER

Oligopeptides for Immunotherapy Approaches in Ovarian Cancer Treatment

Journal: Current Drug Discovery Technologies
Volume: 16, Issue: 3
Page: 285-289
Authors: Darja Kanduc*

Targeting Membrane Receptors of Ovarian Cancer Cells for Therapy

Journal: Current Cancer Drug Targets
Volume: 19, Issue: 6
Page: 449-467
Authors: Zhiquan Liang, Ziwen Lu, Yafei Zhang, Dongsheng Shang, Ruyan Li, Lanlan Liu, Zhicong Zhao, Peishan Zhang, Qiong Lin, Chunlai Feng, Yibang Zhang, Peng Liu, Zhigang Tu* and Hanqing Liu*

Biodistribution, Safety and Organ Toxicity of Docetaxel-Loaded in HER-2 Aptamer Conjugated Ecoflex® Nanoparticles in a Mouse Xenograft Model of Ovarian Cancer

Journal: Recent Patents on Nanotechnology
Volume: 13, Issue: 1
Page: 49-58
Authors: Erfaneh Ghassami, Jaleh Varshosaz*, Mohsen Minaiyan, Mehrab Nasirikenari and Seyed M. Hoseini

Polymeric Micelles of Modified Chitosan Block Copolymer as Nanocarrier for Delivery of Paclitaxel

Journal: Current Nanomedicine
Volume: 9, Issue: 1
Page: 86-96
Authors: V. Lather, V. Saini and D. Pandita*

Current Trends in Cancer Biomarker Discovery Using Urinary Metabolomics: Achievements and New Challenges

Journal: Current Medicinal Chemistry
Volume: 26, Issue: 1
Page: 5-28
Authors: Casey Burton and Yinfa Ma*

DNA Repair Proteins as Therapeutic Targets in Ovarian Cancer

Journal: Current Protein & Peptide Science
Volume: 20, Issue: 4
Page: 316-323
Authors: César López-Camarillo*, Dolores G. Rincón, Erika Ruiz-García, Horacio Astudillo-de la Vega and Laurence A. Marchat

Focal Adhesion Kinase in Ovarian Cancer: A Potential Therapeutic Target for Platinum and Taxane-Resistant Tumors

Journal: Current Cancer Drug Targets
Volume: 19, Issue: 3
Page: 179-188
Authors: Arkene Levy*, Khalid Alhazzani, Priya Dondapati, Ali Alaseem, Khadijah Cheema, Keerthi Thallapureddy, Paramjot Kaur, Saad Alobid and Appu Rathinavelu

Cathepsin L Induces Proangiogenic Changes in Human Omental Microvascular Endothelial Cells via Activation of the ERK1/2 Pathway

Journal: Current Cancer Drug Targets
Volume: 19, Issue: 3
Page: 231-242
Authors: Md Zahidul I. Pranjol, Nicholas J. Gutowski, Michael Hannemann and Jacqueline L. Whatmore*

Formulation and Characterization of Genistein-loaded Nanostructured Lipid Carriers: Pharmacokinetic, Biodistribution and In vitro Cytotoxicity Studies

Journal: Current Drug Delivery
Volume: 16, Issue: 3
Page: 215-225
Authors: Pooja Mittal, Harsh Vrdhan, Gufran Ajmal, Gunjan Bonde, Ramit Kapoor and Brahmeshwar Mishra*

Parallel Solid-Phase Synthesis using a New Diethylsilylacetylenic Linker and Leading to Mestranol Derivatives with Potent Antiproliferative Activities on Multiple Cancer Cell Lines

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 18, Issue: 10
Page: 1469-1481
Authors: Raphaël Dutour, René Maltais, Martin Perreault, Jenny Roy and Donald Poirier*

Synthesis and Anticancer Properties of Novel Truncated Carbocyclic Nucleoside Analogues

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 18, Issue: 10
Page: 1425-1431
Authors: Balija Sivakrishna, Sehbanul Islam, Amarendra Panda, Maddi Saranya, Manas K. Santra* and Shantanu Pal*

Clinical Trials of Novel Targeted Therapies in Ovarian Cancer: Moving Beyond Poly ADP Ribose Polymerase (PARP) Inhibitors

Journal: Current Pharmaceutical Biotechnology
Volume: 19, Issue: 14
Page: 1114-1121
Authors: Quan Guo*, Qing Yang, Jun Li, Guipeng Liu, Igor Nikoulin and Steve Jia

Prognostic Impact of Lymphadenectomy in Different Stages of Malignant Germ Cell Tumor of the Ovary Based on Propensity Score Matching

Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 21, Issue: 9
Page: 652-661
Authors: Ying Chen, Yang Ning, Qinghua Zhang and Ying Xie*

Immunotherapeutic Interleukin-6 or Interleukin-6 Receptor Blockade in Cancer: Challenges and Opportunities

Journal: Current Medicinal Chemistry
Volume: 25, Issue: 36
Page: 4785-4806
Authors: Nirmala Chandralega Kampan, Sue D. Xiang, Orla M. McNally, Andrew N. Stephens, Michael A. Quinn and Magdalena Plebanski*

Surgical Management of the Adnexal Mass

Journal: Current Women`s Health Reviews
Volume: 15, Issue: 1
Page: 23-26
Authors: Kristen Parrish Zeligs* and Elizabeth Jordan*

Evaluation and Management of Adnexal Masses in Postmenopausal Women

Journal: Current Women`s Health Reviews
Volume: 15, Issue: 1
Page: 41-45
Authors: Deepika Nandamuru, Mary K. Collins and Christopher M. Tarney*

Current Clinical Application and Response Prediction Biomarkers of PARP Inhibitors

Journal: Current Pharmacogenomics and Personalized Medicine
Volume: 16, Issue: 2
Page: 108-117
Authors: Wei-Hua Shao, Lei-Yun Wang and Ji-Ye Yin*

Currently Approved Poly (Adenosine Diphosphate-Ribose) Inhibitors in Ovarian Cancer: Current Status and Future Directions

Journal: Clinical Cancer Drugs
Volume: 5, Issue: 1
Page: 3-12
Authors: Gonzalo H. Giornelli and Pablo Mando*

Parp Inhibitors for the Treatment of Ovarian Cancer

Journal: Current Cancer Drug Targets
Volume: 18, Issue: 9
Page: 877-893
Authors: Laura Cortesi, Angela Toss* and Iole Cucinotto

Overall and Multiphasic Findings of the Prostate, Lung, Colorectal and Ovarian (PLCO) Randomized Cancer Screening Trial

Journal: Reviews on Recent Clinical Trials
Volume: 13, Issue: 4
Page: 257-273
Authors: Philip C. Prorok*, Patrick Wright, Thomas R. Riley, Barnett S. Kramer, Christine D. Berg and John K. Gohagan

PARP Inhibitors in Ovarian Cancer

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 13, Issue: 4
Page: 392-410
Authors: Gloria Mittica, Eleonora Ghisoni, Gaia Giannone, Sofia Genta, Massimo Aglietta, Anna Sapino and Giorgio Valabrega*

The Drug Combination of SB202190 and SP600125 Significantly Inhibit the Growth and Metastasis of Olaparib-resistant Ovarian Cancer Cell

Journal: Current Pharmaceutical Biotechnology
Volume: 19, Issue: 6
Page: 506-513
Authors: Xinyan Chen, Yumei Chen, Xueyan Lin, Shan Su, Xiaoman Hou, Qian Zhang and Yongjie Tian*

Anti-cancer Effects of Metformin: Recent Evidences for its Role in Prevention and Treatment of Cancer

Journal: Current Drug Metabolism
Volume: 19, Issue: 9
Page: 793-797
Authors: Masoumeh Kheirandish, Hamidreza Mahboobi*, Maryam Yazdanparast, Warda Kamal and Mohammad Amjad Kamal

Characterization of Liver- and Cancer-type-Organic Anion Transporting Polypeptide (OATP) 1B3 Messenger RNA Expression in Normal and Cancerous Human Tissues

Journal: Drug Metabolism Letters
Volume: 12, Issue: 1
Page: 24-32
Authors: Khondoker Alam, Taleah Farasyn, Kai Ding and Wei Yue*

TC > 0.05 as a Pharmacokinetic Parameter of Paclitaxel for Therapeutic Efficacy and Toxicity in Cancer Patients

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 13, Issue: 3
Page: 341-347
Authors: D.S. Xin, L. Zhou, C.Z. Li, S.Q. Zhang, H.Q. Huang, G.D. Qiu, L.F. Lin, Y.Q. She, J.T. Zheng, C. Chen, L. Fang, Z.S. Chen* and S.Y. Zhang*

Carboxymethyl-hexanoyl Chitosan Nanodroplets for Ultrasonic Imaging and Drug Delivery to Tumor

Journal: Current Pharmaceutical Design
Volume: 24, Issue: 15
Page: 1682-1688
Authors: Yu Jinsui, Situ Bing, Luo Muhua, Li Yue, Liao Jianyi, Du Meng, Cai Kuan, Yang Chaopin, Zhang Hui and Chen Zhiyi*

Comparison of Physicochemical Properties of Generic Doxorubicin HCl Liposome Injection with the Reference Listed Drug

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 18, Issue: 4
Page: 597-609
Authors: Kuntal Maiti *, Subhas Bhowmick, Pankaj Jain, Murlidhar Zope, Keyur Doshi and Thennati Rajamannar

Liquid Chromatography Mass Spectrometry (LCMS) and Phenotype Microarray Profiling of Ovarian Cancer Cells After Exposure to Cisplatin

Journal: Current Metabolomics
Volume: 6, Issue: 2
Page: 112-123
Authors: Sanad Alonezi, Mohammed Al Washih, Carol J. Clements, Louise C. Young, Valerie A. Ferro and David G. Watson*

Fertility Drugs and Ovarian Cancer

Journal: Current Cancer Drug Targets
Volume: 18, Issue: 6
Page: 567-576
Authors: Aus Tariq Ali*

Towards Prevention of Ovarian Cancer

Journal: Current Cancer Drug Targets
Volume: 18, Issue: 6
Page: 522-537
Authors: Aus Tariq Ali*

PARP Inhibitors in Epithelial Ovarian Cancer

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 13, Issue: 2
Page: 145-158
Authors: Kristin N. Taylor and Ramez N. Eskander*

A High-throughput Screening of a Chemical Compound Library in Ovarian Cancer Stem Cells

Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 21, Issue: 1
Page: 50-56
Authors: F. Ricci*, L. Carrassa, M. S. Christodoulou, D. Passarella, B. Michel, R. Benhida, N. Martinet, A. Hunyadi, E. Ioannou, V. Roussis, L. Musso, S. Dallavalle, R. Silvestri, N. Westwood, M. Mori, C. Ingallina, B. Botta, E. Kavetsou, A. Detsi, Z. Majer, F. Hudecz, S. Bosze, B. Kaminska, T.V. Hansen, P. Bertrand, C. M. Athanassopoulos and G. Damia*

Multi-Omics and Machine Learning Applications in Precision Medicine

Journal: Current Pharmacogenomics and Personalized Medicine
Volume: 15, Issue: 2
Page: 97-104
Authors: Eugene Lin and Shih-Jen Tsai*

Immunological and Translational Aspects of Glycolytic Metabolism in Various Human Tumor Entities

Journal: Clinical Immunology, Endocrine & Metabolic Drugs (Discontinued)
Volume: 4, Issue: 1
Page: 37-46
Authors: Stefan Walenta, Kristina Goetze, Nadine Voelxen and Wolfgang Mueller-Klieser*

Current Innovations in Laparoscopy

Journal: Current Women`s Health Reviews
Volume: 14, Issue: 1
Page: 4-10
Authors: Matthew T. Siedhoff*

Synergistic Effect of Graphene Oxide Coated Nanotised Apigenin with Paclitaxel (GO-NA/PTX): A ROS Dependent Mitochondrial Mediated Apoptosis in Ovarian Cancer

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 17, Issue: 12
Page: 1721-1732
Authors: Manish Kumar Pal, Shyam Pyari Jaiswar*, Ashish Dwivedi, Shruti Goyal, Vinay Nand Dwivedi, Anumesh Kumar Pathak, Vinod Kumar, Pushp Lata Sankhwar and Ratan Singh Ray*

Synthesis and Evaluation of Antioxidant and Cytotoxicity of the N-Mannich Base of Berberine Bearing Benzothiazole Moieties

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 17, Issue: 12
Page: 1652-1660
Authors: Bhupendra M. Mistry, Han-Seung Shin, Young-Soo Keum, Muthuraman Pandurangan, Doo Hwan Kim, So Hyun Moon, Avinash A. Kadam, Surendra K. Shinde and Rahul V. Patel*

Enhancement of the Effect of Methyl Pyropheophorbide-a-Mediated Photodynamic Therapy was Achieved by Increasing ROS through Inhibition of Nrf2-HO-1 or Nrf2-ABCG2 Signaling

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 17, Issue: 13
Page: 1824-1836
Authors: Si Tian, Min Yong, Jiang Zhu, Li Zhang, Li Pan, Qing Chen, Kai-Ting Li, Yu-Han Kong , Yuan Jiang, Ting-He Yu, Le-Hua Yu and Ding-Qun Bai*

Clinical Trials with Oncolytic Measles Virus: Current Status and Future Prospects

Journal: Current Cancer Drug Targets
Volume: 18, Issue: 2
Page: 177-187
Authors: Pavlos Msaouel, Mateusz Opyrchal, Angela Dispenzieri, Kah Whye Peng, Mark J. Federspiel, Stephen J. Russell and Evanthia Galanis*

Can We Predict the Sites of the Recurrence of Ovarian Cancer by F-18 FDG PET/CT Depending on CA-125 Level?

Journal: Current Medical Imaging
Volume: 13, Issue: 4
Page: 431-437
Authors: Bulent Turgut*, Esra Ciftci, Seyit Ahmet Erturk, Bulent Cetin, Handan Aker and Zekiye Hasbek

Synthesis and Structure-activity Relationships of Chalcone Derivatives as Inhibitors of Ovarian Cancer Cell Growth

Journal: Letters in Drug Design & Discovery
Volume: 14, Issue: 11
Page: 1259-1266
Authors: Zachary D. Tucker, Francis J. Barrios and Amanda J. Krzysiak*

Cytokine Status of Serum in Ovarian Cancer Patients with Different Tumor Neoadjuvant Chemotherapy Response

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 17, Issue: 9
Page: 1251-1255
Authors: Inna I. Antoneeva, Tatyana V. Abakumova, Dinara R. Dolgova, Tatyana P. Gening*, Sabina S. Pirmamedova, Dinara F. Myasnikova and Snezhanna O. Gening

Effective Strategies and Applications of Dendrimers in the Treatment of Ovarian Cancer

Journal: Current Pharmaceutical Design
Volume: 23, Issue: 21
Page: 3099-3104
Authors: Akila Kesavan, Suresh Babu Pakala, Suresh K. Rayala* and Ganesh Venkatraman*

Targeting Leptin as a Therapeutic Strategy against Ovarian Cancer Peritoneal Metastasis

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 17, Issue: 8
Page: 1093-1101
Authors: Xiao Wei, Yi Liu, Cheng Gong, Teng Ji, Xiaoshui Zhou, Taoran Zhang, Dongyi Wan, Sen Xu, Ping Jin, Xin Yang, Xiaoting Li, Ding Ma, Zongyuan Yang* and Qinglei Gao*

The Benefits and Side Effects of Bevacizumab for the Treatment of Recurrent Ovarian Cancer

Journal: Current Drug Targets
Volume: 18, Issue: 10
Page: 1125-1131
Authors: Wenwen Zhang, Zhaojun Shen, Hui Luo, Xiaoli Hu, Lihong Zheng and Xueqiong Zhu*

Targeted Therapy of Ovarian Cancer with Angiogenesis Inhibitors

Journal: Current Drug Targets
Volume: 18, Issue: 10
Page: 1171-1178
Authors: Ping Duan, Lili Fan, Quansheng Gao, Bal Mukunda Silwal, Mulan Ren, Yang Shen* and Wanglei Qu*

Combination Platinum-based and DNA Damage Response-targeting Cancer Therapy: Evolution and Future Directions

Journal: Current Medicinal Chemistry
Volume: 24, Issue: 15
Page: 1586-1606
Authors: Spyridon P. Basourakos, Likun Li, Ana M. Aparicio, Paul G. Corn, Jeri Kim and Timothy C. Thompson*

Synthesis, Antitubercular and Anticancer Activities of p-nitrophenylethylenediamine- Derived Schiff Bases

Journal: Medicinal Chemistry
Volume: 13, Issue: 4
Page: 391-397
Authors: Raquel S. Amim, Claudia Pessoa, Maria C. S. Lourenco, Marcus V. N. de Souza and Josane A. Lessa*

Exome Sequencing of Ovarian Cancer Patients to Identify Variants Predictive of Sensitivity to Platinum-based Chemotherapy

Journal: Current Pharmacogenomics and Personalized Medicine
Volume: 14, Issue: 2
Page: 124-133
Authors: Assaad Y. Semaan, Kristin R. Delfino, Andrew C. Wilber, Thomas K. Mathews, Kathy J. Robinson, Laurent Brard and Shaheen R. Alanee*

Construction of an Anticancer Fusion Peptide (ACFP) Derived from Milk Proteins and an Assay of Anti-ovarian Cancer Cells in vitro

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 17, Issue: 4
Page: 635-643
Authors: Juan Zhou, Xue Yang, Wenxiao Zhang, Jing Wang, Cai Wei, Fang Gu, Ting Lei and Yide Qin*

Propagation on Molecular Interaction Networks: Prediction of Effective Drug Combinations and Biomarkers in Cancer Treatment

Journal: Current Pharmaceutical Design
Volume: 23, Issue: 1
Page: 5-28
Authors: Balazs Ligeti, Otilia Menyhart, Ingrid Petric, Balazs Gyorffy and Sandor Pongor

Molecular Mechanisms and Potential Treatment Targets for Ovarian Cancer by Analyzing Transcriptional Regulatory Network

Journal: Letters in Drug Design & Discovery
Volume: 14, Issue: 1
Page: 112-118
Authors: Fei Wu, Xinrui Liu, Yujie Sui, Tianmin Xu and Manhua Cui

Noscapine and its Analogs as Chemotherapeutic Agent: Current updates

Journal: Current Topics in Medicinal Chemistry
Volume: 17, Issue: 2
Page: 174-188
Authors: Vartika Tomar, Shrikant Kukreti, Satya Prakash, Jitender Madan and Ramesh Chandra

Role of Colloidal Drug Delivery Carriers in Taxane-mediated Chemotherapy: A Review

Journal: Current Pharmaceutical Design
Volume: 22, Issue: 33
Page: 5127-5143
Authors: Pramod Kumar, Kaisar Raza, Lokesh Kaushik, Ruchi Malik, Shweta Arora and Om Prakash Katare

Overcoming Chemotherapy Resistance in High Grade Serous Ovarian Cancer

Journal: Current Cancer Therapy Reviews
Volume: 12, Issue: 1
Page: 23-36
Authors: Raghav Sundar, David Tan, Lim S. Lei and Whay-Kuang Chia

Evolution of Chemosensitivity and Resistance Assays as Predictors of Clinical Outcomes in Epithelial Ovarian Cancer Patients

Journal: Current Pharmaceutical Design
Volume: 22, Issue: 30
Page: 4717-4728
Authors: Bradley J. Monk, Thomas J. Herzog and Krishnansu S. Tewari

Mechanisms and Therapeutic Targets of microRNA-associated Chemoresistance in Epithelial Ovarian Cancer

Journal: Current Cancer Drug Targets
Volume: 16, Issue: 5
Page: 429-441
Authors: Lingyun Zhang, Lubna Nadeem, Kristin Connor and Guoxiong Xu

Development of Crystalline Cellulosic Fibres for Sustained Release of Drug

Journal: Current Topics in Medicinal Chemistry
Volume: 16, Issue: 18
Page: 2026-2035
Authors: D. Mishra, V. Yadav, Puja Khare, Jyotshna, M. R. Das, Abha Meena and K. Shanker

Recent Patents for Homologous Recombination Deficiency Assays Among Women with Ovarian Cancer

Journal: Recent Patents on Biotechnology
Volume: 9, Issue: 2
Page: 86-101
Authors: Christopher J. LaFargue, Krishnansu S. Tewari and Gareth K. Forde

Targeting of Peptide Cytotoxins to LHRH Receptors For Treatment of Cancer

Journal: Current Drug Targets
Volume: 17, Issue: 5
Page: 488-494
Authors: Jorg B. Engel, Hans-Rudolf Tinneberg, Ferenc G. Rick, Enniko Berkes and Andrew V. Schally

ROS1 Kinase Inhibitors for Molecular-Targeted Therapies

Journal: Current Medicinal Chemistry
Volume: 23, Issue: 2
Page: 142-160
Authors: M.M. Al-Sanea, A.Z. Abdelazem, B.S. Park, K.H. Yoo, T. Sim, Y.J. Kwon and S.H. Lee

Modulation of intracellular pH in human ovarian cancer.

Journal: Current Molecular Medicine
Volume: 16, Issue: 1
Page: 23-32
Authors: C. Sanhueza, J. Araos, L. Naranjo, R. Villalobos, F. Westermeier, C. Salomon, A.R. Beltrán, M.A. Ramírez, J. Gutiérrez, F. Pardo, A. Leiva and L. Sobrevia

Evaluation of a Genetic Counseling Aid for Hereditary Breast and Ovarian Cancer

Journal: Applied Clinical Research, Clinical Trials and Regulatory Affairs
Volume: 2, Issue: 2
Page: 103-109
Authors: Deborah Cragun, Lucia Camperlengo, Emily Robinson, Pauleena Pal, Jongphil Kim, Meghan Caldwell, Jennifer Brzosowicz, Courtney Lewis, Christina Bittner, Susan Vadaparampil and Tuya Pal

Management of Ovarian Cancer In Younger Women

Journal: Reviews on Recent Clinical Trials
Volume: 10, Issue: 4
Page: 263-269
Authors: K. Uma Devi, N. Purushotham and N. Jayashree

Management of Ovarian Cancer in Elderly

Journal: Reviews on Recent Clinical Trials
Volume: 10, Issue: 4
Page: 270-275
Authors: Sushil K. Giri and Bhagyalaxmi Nayak

Management of Fallopian Tube Cancer

Journal: Reviews on Recent Clinical Trials
Volume: 10, Issue: 4
Page: 276-281
Authors: Shweta Rai and Amita Maheshwari

Mitogen-activated Protein Kinase Kinase 6-fusion Protein (MAP2K6-FP) Potentiates the Anti-tumor effects of Paclitaxel in Ovarian Cancer

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 15, Issue: 10
Page: 1308-1316
Authors: Jin Yuan, Jia-Li Kang, Hua Liao, Xiao-xia Wang, Miao-lin Nie, Rong Shuai and Cui Deng

Editorial (Thematic Issue The Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial: The Operations Behind a Herculean Task)

Journal: Reviews on Recent Clinical Trials
Volume: 10, Issue: 3
Page: 172-172
Authors: Pamela M. Marcus

Validation of Self-Report of Chest X-Ray Exam at a Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Center

Journal: Reviews on Recent Clinical Trials
Volume: 10, Issue: 3
Page: 194-199
Authors: Lisa H. Gren, Lois E. Lamerato, Patrick Wright and Pamela M. Marcus

Effects of CAP-regimen Chemotherapy on Blood Redox Status in Patients with Ovarian Cancer

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 15, Issue: 9
Page: 1141-1147
Authors: Inna I. Antoneeva, Dinara R. Dolgova, Tatyana P. Gening, Tatyana V. Abakumova, Snezhanna O. Gening, Sabina S. Pirmamedova, Anastasia V. Fomina and Alla A. Mikheenko

Trebananib (AMG 386): A Non-VEGF Antiangiogenesis Option in Women with Ovarian Cancer

Journal: Current Angiogenesis (Discontinued)
Volume: 3, Issue: 4
Page: 193-202
Authors: Al Wadi Khalid and Ghatage Prafull

Editorial (Thematic Issue: Current Overview of Anti-Angiogenic Therapies for Patients with Epithelial Ovarian Cancer)

Journal: Current Angiogenesis (Discontinued)
Volume: 3, Issue: 4
Page: 175-178
Authors: Samir A. Farghaly

Novel Therapeutic Strategies For Angiogenesis Inhibition In Recurrent Ovarian Cancer

Journal: Current Angiogenesis (Discontinued)
Volume: 3, Issue: 4
Page: 179-192
Authors: Victoria L. Chiou, Elise C. Kohn, Nicole Davarpanah and Jung-Min Lee

Ovarian Cancer - Angiogenesis and Targeted Therapy

Journal: Current Angiogenesis (Discontinued)
Volume: 3, Issue: 4
Page: 215-230
Authors: Kristsanamon Rittiluechai, Naiyarat Prasongsuk, Vincent Vinh-Hung and Claire Verschraegen

Anti-angiogenic Therapy and Induction of Blood Vessel Normalization in the Treatment of Ovarian Cancer

Journal: Current Angiogenesis (Discontinued)
Volume: 3, Issue: 4
Page: 203-214
Authors: Simone Ten Kortenaar, Jack Lawler and Jim Petrik

Synthetic Naphthoflavonoids Showing Inhibitory Effects on Clonogenicity against Cisplatin-Resistant A2780/Cis Human Ovarian Cancer Cells

Journal: Letters in Drug Design & Discovery
Volume: 12, Issue: 8
Page: 628-639
Authors: Yearam Jung, Soon Young Shin, Yeonjoong Yong, Hyuk Yoon, Seunghyun Ahn, Hyeryoung Jung, Dongsoo Koh, Young Han Lee and Yoongho Lim

Synthesis and Evaluation of Anticancer Activity of 5-Ylidene-4- Aminothiazol-2(5H)-one Derivatives

Journal: Medicinal Chemistry
Volume: 11, Issue: 6
Page: 517-530
Authors: Danylo Kaminskyy, Ivanna Subtel’na, Borys Zimenkovsky, Olexandr Karpenko, Andrzej Gzella and Roman Lesyk

TNFR1 Regulates Ovarian Cancer Cell Tumorigenicity Through PIK3CB-p110Beta

Journal: Current Molecular Medicine
Volume: 15, Issue: 5
Page: 487-496
Authors: C. Peng, J. Su, W. Zeng, X. Zhang and X. Chen

Immune Checkpoint Inhibition: Therapeutic Implications in Epithelial Ovarian Cancer

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 10, Issue: 2
Page: 133-144
Authors: Teresa C. Longoria and Ramez N. Eskander

Co-targeting EGFR and Autophagy Impairs Ovarian Cancer Cell Survival during Detachment from the ECM

Journal: Current Cancer Drug Targets
Volume: 15, Issue: 3
Page: 215-226
Authors: Zongyuan Yang, Yi Liu, Xiao Wei, Xiaoshui Zhou, Cheng Gong, Taoran Zhang, Ping Jin, Sen Xu, Ding Ma and Qinglei Gao

Eliminating Ovarian Cancer Stem Cells: A Potential Therapeutic Target for Ovarian Cancer Chemoresistance

Journal: Current Protein & Peptide Science
Volume: 16, Issue: 4
Page: 270-278
Authors: Xiaohui Wang, Xiaolei Li, Xiaoyu Fu, Miaomiao Bai, Xiang Li, Qian Mei, Jing Nie, Zhiqiang Wu and Weidong Han

Low Dose Decitabine Combined with Taxol and Platinum Chemotherapy to Treat Refractory/Recurrent Ovarian Cancer: An Open-Label, Single-Arm, Phase I/II Study

Journal: Current Protein & Peptide Science
Volume: 16, Issue: 4
Page: 329-336
Authors: Xiaoyu Fu, Yan Zhang, Xiaohui Wang, Meixia Chen, Yao Wang, Jing Nie, Yuanguang Meng and Weidong Han

Berberine Exhibits Antitumor Effects in Human Ovarian Cancer Cells

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 15, Issue: 4
Page: 511-516
Authors: Ping Jin, Chunjie Zhang and Na Li

Crystallographic Study and Biological Evaluation of 1,4-dimethyl-N-alkylcarbazoles†

Journal: Current Topics in Medicinal Chemistry
Volume: 15, Issue: 11
Page: 973-979
Authors: Carmela Saturnino, Anna Caruso, Pasquale Longo, Anna Capasso, Attilio Pingitore, Maria Cristina Caroleo, Erika Cione, Mariarita Perri, Francesco Nicolo, Viviana Mollica Nardo, Luigi Monsu Scolaro, Maria Stefania Sinicropi, Maria Rosaria Plutino and Hussein El-Kashef

Genetic Counseling for Hereditary Breast and Ovarian Cancer Among Puerto Rican Women Living in the United States

Journal: Reviews on Recent Clinical Trials
Volume: 9, Issue: 4
Page: 245-253
Authors: Courtney L. Scherr, Elsa Vasquez, Gwendolyn P. Quinn and Susan T. Vadaparampil

Angiogenesis and Anti-angiogenic Therapies in Epithelial Ovarian Cancer

Journal: Current Angiogenesis (Discontinued)
Volume: 3, Issue: 2
Page: 60-65
Authors: Halima Abahssain, Sakina Sekkate, Sihame Lkhoyaali, Patricia Pautier, Hind M’Rabti and Hassan Errihani

In Vitro High Throughput Phage Display Selection of Ovarian Cancer Avid Phage Clones for Near-Infrared Optical Imaging

Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 17, Issue: 10
Page: 859-867
Authors: Mette Soendergaard, Jessica R. Newton-Northup and Susan L. Deutscher

A Novel Multiple Tyrosine-kinase Targeted Agent to Explore the Future Perspectives of Anti-Angiogenic Therapy for the Treatment of Multiple Solid Tumors: Cabozantinib

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 15, Issue: 1
Page: 37-47
Authors: Subhajit Roy, Bawneet K. Narang, Shiva K. Rastogi and Ravindra K. Rawal

Caspases and ROS - Dependent Mechanism of Action Mediated by Combination of WP 631 and Epothilone B

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 14, Issue: 9
Page: 1261-1270
Authors: Aneta Rogalska, Barbara Bukowska and Agnieszka Marczak

SPARC in Tumor Pathophysiology and as a Potential Therapeutic Target

Journal: Current Pharmaceutical Design
Volume: 20, Issue: 39
Page: 6182-6190
Authors: Jianguo Feng and Liling Tang

Ovarian Toxicity: From Environmental Exposure to Chemotherapy

Journal: Current Pharmaceutical Design
Volume: 20, Issue: 34
Page: 5388-5397
Authors: Roberto Iorio, Annalisa Castellucci, Giovanni Ventriglia, Flavia Teoli, Valerio Cellini, Guido Macchiarelli and Sandra Cecconi

Targeting Platinum Resistant Disease in Ovarian Cancer

Journal: Current Medicinal Chemistry
Volume: 21, Issue: 26
Page: 3009-3020
Authors: S.L. Morgan, J.E. Medina, M.M. Taylor and D.M. Dinulescu

Activation of Integrin β1 Mediates the Increased Malignant Potential of Ovarian Cancer Cells Exerted by Inflammatory Cytokines

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 14, Issue: 7
Page: 955-962
Authors: Zongyuan Yang, Xiaoshui Zhou, Yi Liu, Cheng Gong, Xiao Wei, Taoran Zhang, Ding Ma and Qinglei Gao

Synthesis and Stereochemistry-Activity Relationship of Chiral Thiourea Derivatives as Potential Anticancer Agents

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 14, Issue: 6
Page: 910-920
Authors: Vikas Kumar, Akshay Kumar, Vommina V. Sureshbabu and Swapandeep S. Chimni

Synthesis, Antioxidant, Anticancer and Antiviral Activities of Novel Quinoxaline Hydrazone Derivatives and their Acyclic C-Nucleosides

Journal: Medicinal Chemistry
Volume: 10, Issue: 5
Page: 521-532
Authors: Alaa A. El-Tombary and Soad A.M. El-Hawash

Aldose Reductase: A Multi-disease Target

Journal: Current Enzyme Inhibition
Volume: 10, Issue: 1
Page: 2-12
Authors: Jaiprakash N. Sangshetti, Rashmi S. Chouthe, Nikhil S. Sakle, Indrajeet Gonjari and Devanand B. Shinde

Biomarkers for Systemic Therapy in Ovarian Cancer

Journal: Current Cancer Drug Targets
Volume: 14, Issue: 3
Page: 259-273
Authors: Zsofia Penzvalto, Pawel Surowiak and Balazs Gyorffy

Association between MTHFR Gene Polymorphism and the Risk of Ovarian Cancer: A Meta-analysis of the Literature

Journal: Current Pharmaceutical Design
Volume: 20, Issue: 11
Page: 1632-1638
Authors: Danhua Pu, Shi-Wen Jiang and Jie Wu

The Biphasic Expression Pattern of miR-200a and E-cadherin in Epithelial Ovarian Cancer and its Correlation with Clinicopathological Features

Journal: Current Pharmaceutical Design
Volume: 20, Issue: 11
Page: 1888-1895
Authors: Shaohua Xu, Peizhen Xu, Wei Wu, Yangjun Ou, Juan Xu, Guanghua Zhang, Jinping Li and Guofeng Xu

Transcription Factor WT1 and Promoter CpG Hypomethylation Coactivate HOXA10 Expression in Ovarian Cancer

Journal: Current Pharmaceutical Design
Volume: 20, Issue: 11
Page: 1647-1654
Authors: Yi Jiang, Yongli Chu, Weiwei Tang, Yicong Wan, Lin Zhang and Wenjun Cheng